Core Viewpoint - The company, Aikang Guobin, is facing multiple lawsuits from clients alleging misdiagnosis and missed diagnoses during health check-ups, raising concerns about the reliability of its medical services [1][2][3][4] Group 1: Legal Disputes - Aikang Guobin is currently involved in a lawsuit initiated by a client, Ms. Zhang, who claims that the company failed to detect cancer risks during her ten years of health check-ups, leading to her cancer diagnosis in 2024 [1] - Another case involved a client, Mr. Chi, who alleged that Aikang Guobin failed to identify a liver hemangioma during a 2020 check-up, despite it being detected in a previous examination in 2019 [2] - A court ruling found Aikang Guobin liable for not conducting a thorough examination, resulting in Mr. Chi receiving compensation for additional medical expenses [2] Group 2: Court Rulings and Financial Implications - In a separate case, the Ningxia Intermediate People's Court ordered Aikang Guobin to pay a total of 100,000 yuan to a client, Ms. Wang, after failing to detect cervical cancer during her health check-ups in 2012 and 2014 [3][4] - The court established a causal link between Aikang Guobin's negligence in reporting health risks and the delayed diagnosis of Ms. Wang's condition, resulting in significant financial liability for the company [4] - In contrast, another case involving a client, Ms. Zhu, was dismissed by the Shanghai High People's Court due to insufficient evidence linking her claims of negligence to the company's health check-up [4]